home All News open_in_new Full Article

Dyne Therapeutics Announces Orphan Drug Designation for DYNE

Dyne Therapeutics Announces Orphan Drug Designation for DYNE-251 in Japan as DELIVER Trial Shows Promising Results for Duchenne Muscular Dystrophy  Quiver Quantitative


today 9 d. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 1098413096
Add Watch Country

arrow_drop_down